Keystone Symposia

This meeting took place in 2018

Here are the related meetings in 2022:
Heart Failure: Mechanisms and Therapies (Q7)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Heart Failure: Crossing the Translational Divide (A1)

Organizer(s) Yibin Wang, Joseph A. Hill and Carolyn Lam
January 14—18, 2018
Keystone Resort • Keystone, CO USA
Discounted Abstract Deadline: Sep 21, 2017
Abstract Deadline: Oct 19, 2017
Scholarship Deadline: Sep 21, 2017
Discounted Registration Deadline: Nov 20, 2017

Sponsored by Amgen Inc.

Summary of Meeting:
Heart failure is a major human disease that afflicts millions of people worldwide. Intensive research in the past decade has yielded many exciting new mechanistic insights into the pathogenesis of heart failure, but progress toward successful therapies to prevent, halt and reverse heart failure has been painfully slow. The overall goal of this Keystone Symposia conference is to focus on heart failure and highlight the scientific advances in basic discovery and early-phase therapeutic development in this fast-moving field. The symposium will provide the field with an opportunity for robust discussion about the major issues crossing the translational divide from basic discovery to therapies.

View Meeting Program


National Heart, Lung, and Blood Institute (NHLBI) Scholarship Recipients

Anders Olav Garlid
University of California, Los Angeles, USA

Won Suk Jahng
Stanford University, USA

Roy Kalfon
Technion-Israel Institute of Technology, Israel

Kristen Kokkonen-Simon
Eli Lilly and Company, USA

Gabriele G. Schiattarella
University of Texas Southwestern Medical Center, USA

Yao Xiong
University of Pennsylvania, USA